P/B
5,4
Bio-Techne
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
$11.4B
Market Cap • 10/9/2026
1976
(50 years)
Founded
1989
(37 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
9,4
P/EBITDA
32,5
P/OCF
38,9
P/FCF
43,2
P/E
62,5
BVPS
13,4
EPS
1,2
Market Cap
Market Cap
11,4B
EV
11,4B
EV/Revenue
9,4
EV/EBITDA
32,6
EV/EBIT
45,2
Payout
Dividend Per Share
0,3
Dividend Yield
0,4%
Buyback Yield
-0,3%
Total Yield
0,1%
Dividend Yield 5Y
0,5%
Payout
27,4%
Retained Earnings
1,1B
Profitability
Gross Margin
65,8%
EBITDA Margin
28,7%
EBIT Margin
20,7%
Net Margin
15%
D&A/EBITDA
0%
R&D/Revenue
7,8%
Capex/Revenue
2,4%
Capex/D&A
29,6%
Capex/OCF
9,9%
SBC/OCF
14,2%
% PPE
11,6%
% Goodwill
37,7%
ROE
9%
ROIC
8,6%
Growth
CAGR Revenue 5Y
5,5%
CAGR Op. Income 5Y
1,2%
CAGR Net Income 5Y
5,4%
CAGR EPS 5Y
5,9%
CAGR OCF 5Y
-3,7%
Leverage
N.D./EBITDA
0,1
Debt/Equity
0%
Current Ratio
4,5
Quick Ratio
2,9
Interest Coverage
2615,7%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!